Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design

MeSH terms

• Anti-Inflammatory Agents / pharmacology
• Anti-Inflammatory Agents / therapeutic use*
• Biomarkers / analysis
• Cecum / diagnostic imaging
• Cecum / drug effects
• Cecum / immunology
• Cecum / pathology
• Clinical Trials as Topic / standards*
• Colitis, Ulcerative / diagnosis*
• Colitis, Ulcerative / drug therapy
• Colitis, Ulcerative / immunology
• Colon / diagnostic imaging
• Colon / drug effects
• Colon / immunology
• Colon / pathology
• Colonoscopy
• Crohn Disease / diagnosis*
• Crohn Disease / drug therapy
• Crohn Disease / immunology
• Drug Discovery
• Humans
• Ileum / diagnostic imaging
• Ileum / drug effects
• Ileum / immunology
• Ileum / pathology
• Research Design / standards*
• Severity of Illness Index
• Treatment Outcome